1. Introduction {#sec1-marinedrugs-15-00116}
===============

Carotenoids are one of the largest groups of natural pigments in land plants, algae, bacteria including cyanobacteria and photosynthetic bacteria, archaea, fungi and animals \[[@B1-marinedrugs-15-00116],[@B2-marinedrugs-15-00116]\]. More than 750 carotenoids, not including their *cis*- and *trans*- isomers as distinct compounds, have been isolated and characterized from natural sources \[[@B3-marinedrugs-15-00116]\]. Carotenoids not only serve as essential pigments for photosynthesis and photoprotection in photosynthetic organisms, but also comprise many of the yellow, orange and red colors in flowers and fruits that attract pollinators and seed dispersers in higher plants \[[@B4-marinedrugs-15-00116]\]. Abscisic acid and strigolactones are also derivatives of carotenoids \[[@B5-marinedrugs-15-00116]\].

Higher plants generally have very similar leaf carotenoid profiles, with lutein, β-carotene (β,β-carotene), violaxanthin and neoxanthin being the major components. They may also accumulate specific carotenoids, such as capsanthin in pepper fruits \[[@B6-marinedrugs-15-00116]\], β-carotene in carrot tubers \[[@B7-marinedrugs-15-00116]\] and astaxanthin in *Adonis aestivalis* flowers \[[@B8-marinedrugs-15-00116]\]. In the past 20 years, most of the metabolic reactions in the biosynthesis of carotenoids have been deciphered, thanks to the cloning and characterization of genes encoding metabolic enzymes from different organisms \[[@B9-marinedrugs-15-00116]\]. In plants, the plastidic methylerythritol phosphate (MEP) pathway utilizes glyceraldehyde-3-phosphate and pyruvate to synthesize the 5-carbon (C~5~) isopentenyl diphosphate (IPP) and its isomer dimethylallyl diphosphate (DMAPP). A geranylgeranyl diphosphate (GGPP, C~20~) synthase (CrtE) catalyzes the condensation of these two substrates to produce GGPP as a precursor for the biosynthesis of carotenoids and other diterpenoids. Phytoene synthase (CrtB) utilizes two molecules of GGPP to produce phytoene and thus directs the metabolic flux from GGPP into carotenoid metabolic pathway. Phytoene is then converted to acyclic lycopene (ψ,ψ-carotene) by the combination of desaturases CrtP and CrtQ in eukaryotes, but only CrtI in prokaryotes \[[@B2-marinedrugs-15-00116],[@B10-marinedrugs-15-00116]\].

Cyclization of lycopene by lycopene cyclases (LCY) is a crucial bifurcation step in the carotenogenic pathway ([Figure 1](#marinedrugs-15-00116-f001){ref-type="fig"}). Each open end of lycopene can be cyclized by lycopene β-cyclase (LCYB) or ε-cyclase (LCYE) to produce β- or ε-ionone rings, respectively ([Figure 1](#marinedrugs-15-00116-f001){ref-type="fig"}). The formation of two β-ionone rings results in the production of β-carotene and its derivatives (e.g., zeaxanthin and neoxanthin), whereas the combination of β- and ε-ionone rings forms α-carotene (β,ε-carotene) and its derivate lutein ([Figure 1](#marinedrugs-15-00116-f001){ref-type="fig"}). Carotenoids with two ε-ionone rings are uncommon in most plants, with lactucaxanthin in lettuce (*Lactuca sativa*) being one of the exceptions \[[@B11-marinedrugs-15-00116]\]. Carotenes with at least one unsubstituted β-ionone ring can be utilized by the human body to produce vitamin A. Therefore, an increase in the activity of LCYB can direct the metabolic flux from lycopene to the production of this group of so-called provitamin A carotenes to increase the nutritional value of crops \[[@B12-marinedrugs-15-00116],[@B13-marinedrugs-15-00116]\].

Cumulative studies on carotenoids in red algae have uncovered broad compositional diversity \[[@B2-marinedrugs-15-00116],[@B14-marinedrugs-15-00116],[@B15-marinedrugs-15-00116],[@B16-marinedrugs-15-00116]\]. Red algae can also be divided into three groups according to their specific carotenoid compositions \[[@B15-marinedrugs-15-00116],[@B16-marinedrugs-15-00116]\]. Although carotenoid constituents with an ε-ionone ring are missing in some primitive species, β-carotene is found in all red algae, suggesting a ubiquitous distribution of the β-cyclization activity in carotenoid biosynthesis \[[@B16-marinedrugs-15-00116],[@B17-marinedrugs-15-00116]\]. *LCYB* of *Cyanidioschyzon merolae* is also the only *LCY* gene from the entire red alga phylum that has been characterized \[[@B16-marinedrugs-15-00116],[@B17-marinedrugs-15-00116]\].

The red algal genus *Bangia* Lyngb., although probably not monophyletic, is among the earliest multicellular eukaryotic photosynthetic organisms \[[@B18-marinedrugs-15-00116]\]. Carotenoids with both β- and ε-rings, including β-carotene, zeaxanthin, α-carotene and lutein, are accumulated in *Bangia* \[[@B15-marinedrugs-15-00116],[@B16-marinedrugs-15-00116]\]. In this work, we isolated a gene encoding an LCY from *Bangia fuscopurpurea*, and functional characterization revealed that this enzyme has only β-cyclization activity.

2. Results {#sec2-marinedrugs-15-00116}
==========

2.1. BfLCYB Is an Intron-Less LCY Gene {#sec2dot1-marinedrugs-15-00116}
--------------------------------------

From the alignment of functionally characterized LCYs from different organisms, we designed two pairs of degenerate primers. Nested PCR using these primers resulted in amplicons of different sizes. After cloning and sequencing these fragments, a 262 base pair (bp) fragment was found to have high similarity to known LCYs (data not shown). Based on the sequence of this fragment, we successfully amplified a 2218 bp genomic DNA fragment and a 1932 bp complementary DNA (cDNA) encoding a putative protein with 643 amino acid residues, designated BfLCYB in this work ([Figure 2](#marinedrugs-15-00116-f002){ref-type="fig"}A). Sequence alignment demonstrated that *BfLCYB* does not possess any introns. BfLCYB shares 38% sequence identity with the characterized LCYB from *C. merolae* \[[@B17-marinedrugs-15-00116]\]. The sequence of *BfLCYB* has been deposited in GenBank under the accession number KX943552.

Five conserved domains, including an NAD(P)/FAD-binding domain, were previously reported for functionally characterized LCYs \[[@B2-marinedrugs-15-00116],[@B10-marinedrugs-15-00116]\]. These domains were also identified in BfLCYB ([Figure 2](#marinedrugs-15-00116-f002){ref-type="fig"}). However, the NAD(P)/FAD-binding domain in BfLCYB is interrupted by an apparent insertion of 12 additional amino acid residues ([Figure 2](#marinedrugs-15-00116-f002){ref-type="fig"}B). Cunningham and Gantt also identified a six-amino-acid region in LCYE that contributes to the determination of ring numbers in lycopene ε-cyclization products \[[@B11-marinedrugs-15-00116]\]. We found that this region is located immediately downstream from the fifth conserved domain in LCYs ([Figure 2](#marinedrugs-15-00116-f002){ref-type="fig"}F,G). However, in BfLCYB, this region has much lower similarity to other LCYs than either its upstream or downstream flanking regions ([Figure 2](#marinedrugs-15-00116-f002){ref-type="fig"}G).

2.2. BfLCYB Localizes in Chloroplasts {#sec2dot2-marinedrugs-15-00116}
-------------------------------------

From online analysis using TargetP, ChloroP and YLoc, BfLCYB was predicted to have a chloroplast localization \[[@B19-marinedrugs-15-00116],[@B20-marinedrugs-15-00116],[@B21-marinedrugs-15-00116]\]. Its N-terminal chloroplast transit peptide predicted by TargetP and ChloroP is in square brackets in [Figure 2](#marinedrugs-15-00116-f002){ref-type="fig"}A. To experimentally confirm its localization, the open reading frame (ORF) of *BfLCYB* was fused in frame to the 5′-end of the yellow fluorescent protein (*YFP*) in pA7-YFP. Due to the lack of a method to stably transform *Bangia*, we transiently expressed the BfLCYB-YFP fusion protein in *Arabidopsis thaliana* leaf protoplasts \[[@B22-marinedrugs-15-00116]\]. The YFP signal of the fusion protein was solely found in chloroplasts and merged nicely with chlorophyll autofluorescence, thus confirming its predicted chloroplast localization ([Figure 3](#marinedrugs-15-00116-f003){ref-type="fig"}).

2.3. BfLCYB Is a Bicyclic Lycopene β-Cyclase {#sec2dot3-marinedrugs-15-00116}
--------------------------------------------

To determine the enzymatic activity of BfLCYB, we used a bacterial pigment complementation system \[[@B23-marinedrugs-15-00116]\]. The plasmid pAC-LCY contains the genes from *Pantoea* for geranylgeranyl diphosphate synthase (*CrtE*), phytoene synthase (*CrtB*) and phytoene desaturase (*CrtI*). *Escherichia coli* transformed with pAC-LCY can utilize endogenous IPP and DMAPP to produce lycopene, which turns the cells pink ([Figure 4](#marinedrugs-15-00116-f004){ref-type="fig"}A). When we co-transformed *E. coli* with both pMAL-BfLCYB and pAC-LCY, the positive transformants harboring both plasmids had an orange color ([Figure 4](#marinedrugs-15-00116-f004){ref-type="fig"}B). High-performance liquid chromatography (HPLC) analysis revealed an accumulation of both the monocyclic γ-carotene (β,ψ-carotene) and the bicyclic β-carotene in these orange cells ([Figure 4](#marinedrugs-15-00116-f004){ref-type="fig"}B). We did not find accumulation of either ε-carotene (ε,ε-carotene) or δ-carotene (ε,ψ-carotene) in the co-transformed bacteria. These results suggested that BfLCYB is able to cyclize one or both ends of lycopene into β-ionone rings but not ε-ionone rings.

We further confirmed the function of BfLCYB by co-transforming pMAL-BfLCYB with pAC-EPSILON. In addition to the genes carried by pAC-LCY, pAC-EPSILON carries the gene from lettuce for LCYE, which catalyzes the ε-cyclization at both ends of lycopene \[[@B11-marinedrugs-15-00116]\]. *E. coli* cells transformed with pAC-EPSILON accumulated ε-carotene, as expected ([Figure 4](#marinedrugs-15-00116-f004){ref-type="fig"}C). When this plasmid was co-transformed with pMAL-BfLCYB, HPLC analysis revealed the accumulation of both α-carotene and β-carotene, together with a significantly reduced level of ε-carotene and a small amount of γ-carotene ([Figure 4](#marinedrugs-15-00116-f004){ref-type="fig"}D). This demonstrated that BfLCYB can also β-cyclize the open end of monocyclic δ-carotene.

2.4. BfLCYB Is an Ancient Type of Lycopene Cyclase in Plants {#sec2dot4-marinedrugs-15-00116}
------------------------------------------------------------

Using sequences of functionally characterized LCYs, we identified LCY homologs in heterokonts and red algae of which full genomes have been sequenced. For heterokonts, in the genome of either *Ectocarpus siliculosus* (brown alga) or *Phaeodactylum tricornutum* (diatom), there is only a single gene encoding an LCY homolog ([Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}A). However, for the multicellular red alga *Chondrus crispus*, our search identified two genes for putative LCYs in its genome ([Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}A). Our phylogenetic analysis divided LCYs and their homologs into five major clades. Clade I comprises members from single-cell red algae, including the LCYB from *Cyanidioschyzon merolae* and a homolog from *Galdieria sulphuraria*. Clade II has members from multicellular red algae, including BfLCYB in this study and the two homologs from *Chondrus crispus*. Clade IV has LCY homologs from heterokonts. The other two clades, III and V, are LCYBs and LCYEs, respectively, from the green lineage (green algae and land plants) ([Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}A).

A recently study by Blatt et al. \[[@B24-marinedrugs-15-00116]\] reported a gene (*OluLCY*) encoding a lycopene β-cyclase/lycopene ε-cyclase/light-harvesting complex-fusion protein from the green alga *Ostreococcus lucimarinus*. Our sequence analysis of this gene identified two coding regions (*OluLCY-B* and *OluLCY-E*) that are tandemly arranged, separated by a short intron ([Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}B). In our phylogenetic tree, peptides encoded by these two regions are grouped with functionally characterized LCYBs and LCYEs, respectively ([Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}B).

3. Discussion {#sec3-marinedrugs-15-00116}
=============

In green lineage organisms (green algae and land plants), carotenoids with both β- and ε-rings are found, and separate LCYBs and LCYEs catalyzing the corresponding cyclization steps are also characterized from different species \[[@B1-marinedrugs-15-00116],[@B25-marinedrugs-15-00116]\]. Our phylogenetic analysis clustered LCYBs and LCYEs from these organisms into separate clades (IV and V, [Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}), showing a divergence of lycopene β- and ε-cyclase activities (Clades IV and V, [Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}A) before the origination of the green lineage. This is also supported by the identification of the *OluLCY* gene, which has two tandemly arranged regions for peptides with LCYB and LCYE activities, respectively, suggesting probable gene duplication and divergence.

In red algae and heterokonts, although their carotenoid constituents have been studied, there is not sufficient information on their LCYs \[[@B2-marinedrugs-15-00116],[@B26-marinedrugs-15-00116]\]. In both single-cell red algae and heterokonts, only β-carotene and its derivatives were found. Consistently, LCYs from *Cyanidioschyzon merolae* possess only β-cyclization activity, and studies in diatoms found no sequences showing similarity to *LCYE* genes either \[[@B16-marinedrugs-15-00116],[@B26-marinedrugs-15-00116],[@B27-marinedrugs-15-00116],[@B28-marinedrugs-15-00116]\]. Therefore, it is reasonable to postulate that members of Clades I and IV in [Figure 5](#marinedrugs-15-00116-f005){ref-type="fig"}A are all LCYBs.

For multicellular red algae, which accumulates carotenoids with both β- and ε-rings, studies on their LCYs are lacking. In this work, we studied lycopene cyclization in *Bangia fuscopurpurea*, which is considered to be one of the simplest macrophytic red algae. Our molecular cloning and functional characterization results demonstrated that *B. fuscopurpurea* has a functional LCYB (BfLCYB), which is capable of catalyzing β-cyclization at both ends of the acyclic lycopene or at either end of the monocyclic γ-carotene or δ-carotene. By scanning the genome sequence of another multicellular red alga, *Chondrus crispus*, we found two homolog genes for LCYs. These remind us of the possible existence of another as-yet-unidentified LCYE homolog responsible for ε-cyclization in *B. fuscopurpurea*. Cloning and functional characterization of this second LCY from *B. fuscopurpurea* should help to decipher carotenoid metabolism and its evolution in red algae.

4. Materials and Methods {#sec4-marinedrugs-15-00116}
========================

4.1. Material and Growth Condition {#sec4dot1-marinedrugs-15-00116}
----------------------------------

Thalli of *Bangia fuscopurpurea* (\#Bangia-MC1F, Jiangsu Institute of Oceanology and Marine Fisheries, Nantong, Jiangsu, China) were initially collected from cultivated populations in Putian, Fujian Province, China (24°59′ N, 118°48′ E) \[[@B29-marinedrugs-15-00116]\] and then subcultured in sterilized seawater in our laboratory. Ambient air filtered through a 0.45 μm filter was gently supplied to the culture. The growth conditions were 16 °C with a 12 h/12 h light/dark regime under 80 μmol m^−2^ s^−1^ irradiance. Seawater was changed every week.

4.2. Sequence Analysis {#sec4dot2-marinedrugs-15-00116}
----------------------

Sequences of functionally characterized LCYs from *Zea mays*, *Oryza sativa*, *Arabidopsis thaliana*, *Ipomoea batatas*, *Adonis aestivalis*, *Marchantia polymorpha*, *Chromochloris zofingiensis*, *Dunaliella salina*, *Ostreococcus lucimarinus* and *Cyanidioschyzon merolae* were downloaded from GenBank, and their homologs in *Ectocarpus siliculosus*, *Phaeodactylum tricornutum*, *Chondrus crispus* and *Galdieria sulphuraria* were searched in GenBank using the blastP algorithm with the sequences of known LCYs as queries. Sequence alignment was performed using ClustalW in MEGA 6 \[[@B30-marinedrugs-15-00116]\]. A bootstrap (1000 replicates) neighbor-joining phylogenetic tree was also generated using MEGA 6. 4.3. Molecular manipulation.

Total RNA was isolated from *Bangia fuscopurpurea* material as previously described \[[@B31-marinedrugs-15-00116]\] and treated with DNase (Promega, Madison, WI, USA) to eliminate any genomic DNA contamination. For rapid amplification of cDNA ends (RACE), the SMARTer RACE cDNA Amplification Kit (TaKaRa, Shiga, Japan) was used to synthesize a full-length cDNA pool.

According to the alignment of the functionally characterized LCYs, two pairs of degenerate primers (DF1/DR1, DF2/DR2, sequences of all primers used in this work are listed in [Table 1](#marinedrugs-15-00116-t001){ref-type="table"}) were designed from the conserved regions \[[@B32-marinedrugs-15-00116]\], and used for amplifying a corresponding fragment from the *B. fuscopurpurea* cDNA pool. After two rounds of nested PCR, amplified products were subcloned and sequenced by GenScript (Nanjing, China). The sequences of the cloned fragments were queried against GenBank using the tblastX algorithm to analyze their similarities to known or predicted *LCY* genes.

Using the sequences that had high similarity to known *LCY*s, three pairs of primers (RF1/RR1, RF2/RR2 and RF3/RR3) were designed for 5′- and 3′-RACEs, respectively, using the SMARTer RACE kit. After three rounds of nested PCR, two overlapping fragments were amplified from the cDNA pool, subcloned and sequenced. The sequences were assembled into a putative cDNA sequence that contained both translation initiation and stop codons. We then designed an additional pair of primers (HF and ER) from the assembled sequence to amplify the full-length ORF from the cDNA pool for confirming the existence of this transcript (named *BfLCYB*).

To study the genomic sequence of *BfLCYB*, genomic DNA was extracted according to Yang et al. \[[@B31-marinedrugs-15-00116]\]. Primers HF and ER were used to amplify its coding region. A Genome Walking Kit (TaKaRa) was used to amplify the 5′ and 3′ flanking sequences. All amplicons were purified, subcloned, sequenced and assembled. Two primers (gHF and gER) were used to amplify from the genomic DNA for confirming the assembled genomic DNA sequence of *BfLCYB*.

4.3. Subcellular Localization {#sec4dot3-marinedrugs-15-00116}
-----------------------------

Prediction of the subcellular localization of BfLCYB was performed using TargetP \[[@B19-marinedrugs-15-00116]\], YLoc \[[@B20-marinedrugs-15-00116]\] and ChloroP \[[@B21-marinedrugs-15-00116]\].

For studying the subcellular localization of BfLCYB, protoplasts isolated from *Arabidopsis thaliana* mesophyll were transiently transformed \[[@B22-marinedrugs-15-00116]\]. The full-length ORF of *BfLCYB* was amplified with primers HF-SpeI and ER-SpeI to incorporate restriction sites. The amplicon was purified, digested with SpeI, and subcloned into pA7-YFP (kindly provided by Dr. Hongquan Yang). The transformed protoplasts were cultured in 24-well plates at room temperature for 16 h in the dark. Fluorescence signal from the BfLCYB-YFP fusion protein was observed using a confocal laser scanning microscope (Olympus FluoView FV1000, Tokyo, Japan). The transient expression experiments were repeated independently at least three times.

4.4. Functional Characterization {#sec4dot4-marinedrugs-15-00116}
--------------------------------

To assess the catalytic activity of BfLCYB, we used the pigment complementation system \[[@B23-marinedrugs-15-00116]\]. Two vectors, pAC-LCY and pAC-EPSILON were provided by Dr. Cunningham. The full-length ORF of *BfLCYB* was amplified with primers HF-BamHI and ER-BamHI to incorporate restriction sites. The amplified product was subcloned into pMAL-C5X (New England BioLabs, Ipswich, MA, USA) to produce pMAL-BfLCYB. pMAL-BfLCYB was co-transformed with pAC-LCY, or pAC-ΕPSILON, into *E. coli* BL21(DE3) cells (New England BioLabs, Ipswich, MA, USA). After overnight growth at 37 °C on Luria-Bertani (LB), plants containing 34 μg mL^−1^ chloramphenicol and 100 μg mL^−1^ ampicillin, positive co-transformed single colonies were picked and used to inoculate 8 mL LB medium containing the same antibiotics. One mL of the overnight culture was transferred to 100 mL of the same medium and grown at 37 °C until reaching an OD600 of 0.30. Protein expression was induced by adding isopropyl β-thiogalactopyranoside (IPTG) to a final concentration of 50 μmol L^−1^. After growing for 16 h at 18 °C, bacterial cells were harvested by centrifugation and resuspended in 80% (*v*/*v*) acetone to extract the pigments.

4.5. Carotenoid Analysis {#sec4dot5-marinedrugs-15-00116}
------------------------

Separation of carotenoid components was performed by reverse-phase HPLC \[[@B33-marinedrugs-15-00116]\]. A Waters 2695 separation module and 2998 photodiode array detector (PDA) were used with a Spherisorb ODS2 column (5 μm, 4.6 mm × 250 mm, Waters, Milford, MA, USA). A 45 min gradient of ethyl acetate (0% to 100%) in acetonitrile-water-triethylamine (9:1:0.01, *v/v/v*) at a flow rate of 1 mL min^−1^ was used, and the absorbance of the eluent at 440 nm was monitored \[[@B34-marinedrugs-15-00116]\]. The identity of the carotenoid in each peak was further confirmed by their UV/visible spectra recorded by the PDA detector.
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![Cyclization of lycopene catalyzed by lycopene β-cyclase (LCYB) and ε-cyclase (LCYE).](marinedrugs-15-00116-g001){#marinedrugs-15-00116-f001}

![Sequence analysis of BfLCYB. (**A**) *BfLCYB* complementary DNA (cDNA) sequence and its deduced amino acid sequence. Sequence of the predicted N-terminal chloroplast transit peptide is in red. (**B**--**F**) Sequence comparison of the NAD(P)/FAD-binding domain (**B**) and other conserved domains (**C**--**F**). (**G**) Sequence comparison of the six-amino-acid region (in bold) that determines ring numbers of LCYE and flanking regions. The conserved domains in BfLCYB are in blue and indicated by superscript letters, and the ring number-determination region in BfLCYB is underlined in (**A**). Sequences of functionally characterized LCYEs from *Adonis aestivalis* (Aa-2, AAK07430.1), *Oryza sativa* (Os-2, XP_015622198.1) and *Arabidopsis thaliana* (At-2, NP_200513.1) and LCYBs from *A. aestivalis* (Aa-1, AAK07432.1), *O. sativa* (Os-1, XP_015627234.1), *A. thaliana* (At-1, NP_187634.1), *Dunaliella salina* (Ds-1, ACA34344.1; Ds-2, ANY98896.1), *Cyanidioschyzon merolae* (Cm-1, XP_005536481.1) and *Bangia fuscopurpurea* (Bf-1, KX943552) were compared.](marinedrugs-15-00116-g002){#marinedrugs-15-00116-f002}

![Subcellular localization of BfLCYB. The BfLCYB yellow fusion protein (BfLCYB-YFP) was transiently expressed in *Arabidopsis thaliana* protoplasts, and observed under a confocal microscope. Signals from the fusion protein (**A**) and chlorophyll autofluorescence (**B**) were merged (**C**) for a comparison with the protoplast observed under bright field (**D**). The transient expression experiment was repeated independently five times and only one representative protoplast is shown here. Scale bar, 5 μm.](marinedrugs-15-00116-g003){#marinedrugs-15-00116-f003}

![Functional characterization of BfLCYB. (**A**) Production of lycopene in *Escherichia coli* cells transformed with pAC-LCY. (**B**) Production of γ-carotene and β-carotene in *E. coli* cells transformed with both pAC-LCY and pMAL-BfLCY1. (**C**) Production of ε-carotene in *E. coli* cells transformed with pAC-EPSILON. (**D**) Production of α-, ε-, γ- and β-carotene in *E. coli* cells transformed with both pAC-EPSILON and pMAL-BfLCYB. (**E**) UV-visible absorption spectra of different carotenoid products. Insets in (**A**,**B**) showed different colors of the pelleted bacterial cells accumulating lycopene and β-carotene, respectively.](marinedrugs-15-00116-g004){#marinedrugs-15-00116-f004}

![Phylogenetic analysis of plant LCYs. (**A**) Sequences of the functionally characterized LCYs from *Zea mays* (LCYB, NP_001169155.1; LCYE, NP_001146840.1), *Oryza sativa* (LCYB, XP_015627234.1; LCYE, XP_015622198.1), *Arabidopsis thaliana* (LCYB, NP_187634.1; LCYE, NP_200513.1), *Ipomoea batatas* (LCYB, AGL44392.1; LCYE, BAW34178.1), *Adonis aestivalis* (LCYB, AAK07430.1; LCYE, AAK07432.1), *Marchantia polymorpha* (LCYB, BAO27799.1; LCYE, BAO27800.1), *Chromochloris zofingiensis* (LCYB, CBH31263.1; LCYE, CCG06343.1), *Dunaliella salina* (LCYB1, ACA34344.1; LCYB2, ANY98896.1), *Ostreococcus lucimarinus* (LCYB, XP_001422489.1; LCYE, XP_001422490.1), *Bangia fuscopurpurea* (LCYB, KX943552) and *Cyanidioschyzon merolae* (XP_005536481.1), and their homologs from *Ectocarpus siliculosus* (CBN78004.1), *Phaeodactylum tricornutum* (XP_002176612.1), *Chondrus crispus* (1, XP_005713399.1; 2, XP_005715292.1) and *Galdieria sulphuraria* (XP_005708098.1) are analyzed using MEGA 6. Scale bar, 10% sequence divergence. (**B**) Structure of the *Ostreococcus lucimarinus LCY* gene that has two tandemly arranged regions for LCYB (OluLCY-B) and LCYE (OluLCY-E) activities.](marinedrugs-15-00116-g005){#marinedrugs-15-00116-f005}

marinedrugs-15-00116-t001_Table 1

###### 

Primers used in this work.

  Primer        Sequence (5′-3′) ^1,2^
  ------------- ------------------------------------------
  DF1           MMNAAYTAYGGNKKNTGGBWNGAYGAR
  DR1           GGRTGNACSADNSHNGCNGYNSCNCCNAWNSC
  DF2           ATGBTNYTNATGGAYKDNMGNGA
  DR2           RNVNNCCNCCNAYNGGDATNWV
  RR1           GGCCCCCCCATGGGGATCAGACAAAACTC
  RR2           CAGACAAAACTCCTCATCGAGCACCCGC
  RR3           CACCCGCGTCACGGTGATGCCGTC
  RF1           GGTGCTGATGGACTACCGGGATGG
  RF2           GGGATGGGCACATGCAGGGGGAC
  RF3           GGACGCCGCGGGGCGGGCCGAGTC
  HF            ATGGAGGCGTTCATCCCCGCCTC
  ER            CTACGCCTCGTCCTCTGGCAGCGG
  gHF           AATCAGTCAGTTTCGGTGATCTTTC
  gER           CCGCCGAAACGGCCTACCCCT
  SpeI-LCY-F    G[ACTAGT]{.ul}ATGGAGGCGTTCATCCCCGCCTC
  SpeI-LCY-R    GGG[ACTAGT]{.ul}CTACGCCTCGTCCTCTGGCAGCGG
  BamHI-LCY-F   [GGATCC]{.ul}ATGGAGGCGTTCATCCCCGCCTC
  BamHI-LCY-R   GG[GGATCC]{.ul}CTACGCCTCGTCCTCTGGCAGCGG

**^1^** Codes for degenerate nucleotides are M (A/C), R (A/G), W (A/T), S (C/G), Y (C/T), K (G/T), V (A/C/G), H (A/C/T), D (A/G/T), B (C/G/T) and N (any nucleotide); **^2^** Restriction sites are underlined.
